Advances in mRNA vaccines.

Li, Mengyun; Wang, Zining; Xie, Chunyuan; Xia, Xiaojun

Li, Mengyun; Wang, Zining; Xie, Chunyuan; Xia, Xiaojun.

Afiliação

Li M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wang Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Xie C; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Xia X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. Electronic address: xiaxj@sysucc.org.cn.

Int Rev Cell Mol Biol ; 372: 295-316, 2022.

Article em En | MEDLINE | ID: mdl-36064266

Assuntos

COVID-19; Nanopartículas; COVID-19/prevenção & controle; Humanos; Lipossomos; Nucleosídeos; RNA Mensageiro/genética; Vacinas Sintéticas; Vacinas de mRNA

Palavras-chave

Cancer vaccine; In vitro transcription; Lipid nanoparticle; Neoantigen; mRNA vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Nanopartículas / COVID-19 Limite: Humans Idioma: En Revista: Int Rev Cell Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google